(Q36968256)

17 August 2017

1 reference

title

Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation (English)

1 reference

17 August 2017

0 references

Stanley L Hem

1

1 reference

PubMed ID

17931150

17 August 2017

Harm Hogenesch

series ordinal

2

1 reference

17 August 2017

1 October 2007

1 reference

Expert Review of Vaccines

17 August 2017

1 reference

17 August 2017

6

1 reference

17 August 2017

5

1 reference

17 August 2017

685-698

1 reference

Aluminum compounds used as adjuvants in vaccines

17 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Surface phosphophilicity of aluminum-containing adjuvants probed by their efficiency for catalyzing the P--O bond cleavage with chromogenic and fluorogenic substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Measuring the surface area of aluminum hydroxide adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Distribution of adsorbed antigen in mono-valent and combination vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

In vivo absorption of aluminium-containing vaccine adjuvants using 26Al.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Studies on antibody production. III. The alum granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Mechanisms of stimulation of the immune response by aluminum adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Enhancement of DNA vaccine potency using conventional aluminum adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Homing of naive, memory and effector lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Visualizing the generation of memory CD4 T cells in the whole body

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Mechanisms of antigen uptake for presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Control of adaptive immune responses by Toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

DAMPs, PAMPs and alarmins: all we need to know about danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

New insights into the mechanism of IL-1beta maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.685

21 January 2018

Identifiers

DOI

10.1586/14760584.6.5.685

1 reference

17 August 2017

1 reference

PubMed ID

17931150